Nephros Dirección
Dirección controles de criterios 3/4
El CEO de Nephros es Robert Banks , nombrado en May 2023, tiene una permanencia de 3.33 años. compensación anual total es $627.13K, compuesta por 57.8% salario y 42.2% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.75% de las acciones de la empresa, por valor de $818.90K. La antigüedad media del equipo directivo y de la junta directiva es de 3.7 años y 4 años, respectivamente.
Información clave
Robert Banks
Chief Executive Officer (CEO)
US$627.1k
Compensación total
| Porcentaje del salario del CEO | 57.80% |
| Permanencia del CEO | 3.3yrs |
| Participación del CEO | 1.7% |
| Permanencia media de la dirección | 3.7yrs |
| Promedio de permanencia en la Junta Directiva | 4yrs |
Actualizaciones recientes de la dirección
Recent updates
NEPH: Index Additions And M&A Options Will Shape Balanced Future Outlook
Nephros has seen its analyst price target move from about $4.00 to roughly $4.75, with analysts citing expectations for higher revenue growth and stronger profit margins. They also recognize its five nanometer ultrafilter as a key product, while monitoring for growth to reaccelerate beyond 20%.
NEPH: Index Additions And Water Filtration Leadership Will Support Future Upside
Analysts trimmed their fair value estimate for Nephros from $7 to $6, citing a higher future P/E assumption of about 50x and a weaker profit margin outlook. They also highlight the company's five nanometer ultrafilter and indicate they would like to see revenue growth trends improve further before becoming more positive on the stock.NEPH: Index Additions And Mergers Will Shape Future Trading Profile
Analysts now see Nephros shares fairly valued closer to $4.00 per share, aligning with a new $4 price target that reflects confidence in its ultrafilter technology, while also recognizing that recent gains already capture much of the anticipated growth until revenue expansion re-accelerates above 20%. What’s in the News for Nephros Nephros is actively seeking acquisitions, merger partners, and business development investments, with management indicating an interest in opportunities that they view as offering a significantly higher return on investment, source: Nephros investor event.Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Lifting Their Price Targets
It's been a pretty great week for Nephros, Inc. ( NASDAQ:NEPH ) shareholders, with its shares surging 15% to US$3.52 in...Is Nephros, Inc. (NASDAQ:NEPH) Potentially Undervalued?
Nephros, Inc. ( NASDAQ:NEPH ), might not be a large cap stock, but it saw a decent share price growth of 19% on the...Nephros, Inc.'s (NASDAQ:NEPH) Popularity With Investors Under Threat As Stock Sinks 28%
Nephros, Inc. ( NASDAQ:NEPH ) shareholders won't be pleased to see that the share price has had a very rough month...Is It Time To Consider Buying Nephros, Inc. (NASDAQ:NEPH)?
Nephros, Inc. ( NASDAQ:NEPH ), is not the largest company out there, but it received a lot of attention from a...Nephros (NASDAQ:NEPH) Is Experiencing Growth In Returns On Capital
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...Why Investors Shouldn't Be Surprised By Nephros, Inc.'s (NASDAQ:NEPH) 27% Share Price Surge
Nephros, Inc. ( NASDAQ:NEPH ) shareholders would be excited to see that the share price has had a great month, posting...At US$4.26, Is Nephros, Inc. (NASDAQ:NEPH) Worth Looking At Closely?
Nephros, Inc. ( NASDAQ:NEPH ), is not the largest company out there, but it saw a significant share price rise of 47...It's Down 26% But Nephros, Inc. (NASDAQ:NEPH) Could Be Riskier Than It Looks
NasdaqCM:NEPH 1 Year Share Price vs Fair Value Explore Nephros's Fair Values from the Community and select yours...Nephros, Inc.'s (NASDAQ:NEPH) 79% Jump Shows Its Popularity With Investors
Despite an already strong run, Nephros, Inc. ( NASDAQ:NEPH ) shares have been powering on, with a gain of 79% in the...Should You Think About Buying Nephros, Inc. (NASDAQ:NEPH) Now?
Nephros, Inc. ( NASDAQ:NEPH ), is not the largest company out there, but it led the NASDAQCM gainers with a relatively...Investors Still Aren't Entirely Convinced By Nephros, Inc.'s (NASDAQ:NEPH) Revenues Despite 32% Price Jump
Nephros, Inc. ( NASDAQ:NEPH ) shares have had a really impressive month, gaining 32% after a shaky period beforehand...It's A Story Of Risk Vs Reward With Nephros, Inc. (NASDAQ:NEPH)
There wouldn't be many who think Nephros, Inc.'s ( NASDAQ:NEPH ) price-to-sales (or "P/S") ratio of 1.2x is worth a...We're Not Worried About Nephros' (NASDAQ:NEPH) Cash Burn
We can readily understand why investors are attracted to unprofitable companies. For example, although...Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Cutting Their Estimates
Shareholders might have noticed that Nephros, Inc. ( NASDAQ:NEPH ) filed its quarterly result this time last week. The...After Leaping 40% Nephros, Inc. (NASDAQ:NEPH) Shares Are Not Flying Under The Radar
Nephros, Inc. ( NASDAQ:NEPH ) shares have continued their recent momentum with a 40% gain in the last month alone. The...At US$3.18, Is It Time To Put Nephros, Inc. (NASDAQ:NEPH) On Your Watch List?
Nephros, Inc. ( NASDAQ:NEPH ), might not be a large cap stock, but it received a lot of attention from a substantial...Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2026 | n/a | n/a | US$2m |
| Mar 31 2026 | n/a | n/a | US$776k |
| Dec 31 2025 | US$627k | US$363k | US$1m |
| Sep 30 2025 | n/a | n/a | US$1m |
| Jun 30 2025 | n/a | n/a | US$1m |
| Mar 31 2025 | n/a | n/a | US$801k |
| Dec 31 2024 | US$410k | US$350k | US$74k |
| Sep 30 2024 | n/a | n/a | -US$929k |
| Jun 30 2024 | n/a | n/a | -US$1m |
| Mar 31 2024 | n/a | n/a | -US$1m |
| Dec 31 2023 | US$824k | US$229k | -US$2m |
Compensación vs. Mercado: La compensación total ($USD627.13K) de Robert está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD654.65K).
Compensación vs. Ingresos: La compensación de Robert ha aumentado más de un 20% en el último año.
CEO
Robert Banks (51 yo)
Mr. Robert Banks is President, Director & CEO of Nephros, Inc. from May 2023. Mr. Banks has a proven track record of delivering value through innovation and aligning the strengths of his organizations with...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 3.3yrs | US$627.13k | 1.75% $ 818.9k | |
| Chief Financial Officer | 2.8yrs | US$322.62k | 0.63% $ 296.8k | |
| Director of Brand | 3.7yrs | sin datos | sin datos | |
| Vice President of Quality | 4.7yrs | sin datos | sin datos | |
| President of Aether Water Systems | 5.9yrs | sin datos | sin datos | |
| Controller | 3.7yrs | sin datos | sin datos | |
| Vice President of R&D | 9.6yrs | sin datos | sin datos |
Equipo directivo experimentado: El equipo directivo de NEPH se considera experimentado (3.7 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 3.3yrs | US$627.13k | 1.75% $ 818.9k | |
| Director | 19yrs | US$33.67k | 1.7% $ 793.8k | |
| Independent Director | 8.1yrs | US$44.22k | 1.13% $ 529.6k | |
| Independent Director | 4yrs | US$23.00k | 0.16% $ 76.3k | |
| Director | 1.3yrs | US$49.00k | 0.015% $ 7.0k |
Junta con experiencia: La junta directiva de NEPH se considera experimentada (4 años de antigüedad promedio).
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/09/21 02:35 |
| Precio de las acciones al final del día | 2026/09/21 00:00 |
| Beneficios | 2026/06/30 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Nephros, Inc. está cubierta por 4 analistas. 3 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Marc Wiesenberger | B. Riley Securities, Inc. |
| Anthony Vendetti | Maxim Group |
| Robert Brooks | Northland Capital Markets |